Search results

If your application is for ethical approval of a gene therapy clinical trial you must apply to the Gene Therapy Advisory Committee (GTAC).

It is vital to the success of your project that you consider at an early stage how and where participants will be identified, recruited and participate in your project.

We are committed to providing a service that promotes human rights, equality and diversity and does not discriminate against any staff, potential staff, members, partners, service users or anyone that deals with us in any way.

The FOI Act requires that each public authority adopts and maintains a publication scheme that describes the classes of information that the Authority publishes or intends to publish. We will regularly review this publication scheme and update it where necessary, subject to approval from the Information Commissioner.

This area covers all live consultations and calls for good practice or evidence.

The Over-Volunteering Prevention System (TOPS) is a database, free to all UK organisations undertaking Phase I trials in healthy volunteers, that aims to prevent participants from taking part too frequently in trials of new medicines.

The National Research and Ethics Advisors' Panel (NREAP) is an independent, multidisciplinary expert panel which provides advice to the Health Research Authority (HRA) on an ad-hoc basis. The panel encompasses expertise in a wide range of disciplines related to health research including bioethics, medical research, patient and public involvement and Research Ethics Committees (RECs).

This section outlines both meeting dates and minutes for CAG meetings. Valid applications received by the relevant submission dates can expect to receive an approval decision from the Secretary of State for Health (non-research) or Health Research Authority (research) within a maximum of 60 working days.